🇺🇸 FDA
Pipeline program

C1 Esterase Inhibitor Injection [Cinryze]

NL76082.058.20

Phase 2 small_molecule active

Quick answer

C1 Esterase Inhibitor Injection [Cinryze] for Subarachnoid Hemorrhage, Aneurysmal is a Phase 2 program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
TAKEDA PHARMACEUTICAL CO LTD
Indication
Subarachnoid Hemorrhage, Aneurysmal
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials